Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-small-cell lung cancers: a heterogeneous set of diseases
Chen Zhao, Christine M. Fillmore, Peter S. Hammerman, et al.
Nature reviews. Cancer (2014) Vol. 14, Iss. 8, pp. 535-546
Open Access | Times Cited: 1668

Showing 1-25 of 1668 citing articles:

The lung microenvironment: an important regulator of tumour growth and metastasis
Nasser K. Altorki, Geoffrey J. Markowitz, Dingcheng Gao, et al.
Nature reviews. Cancer (2018) Vol. 19, Iss. 1, pp. 9-31
Open Access | Times Cited: 897
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Nayoung Kim, Hong Kwan Kim, Kyungjong Lee, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 869
Long‐term expanding human airway organoids for disease modeling
Norman Sachs, Angelos Papaspyropoulos, Domenique D. Zomer-van Ommen, et al.
The EMBO Journal (2019) Vol. 38, Iss. 4
Open Access | Times Cited: 826
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim, Hyemin Mun, Chang Ohk Sung, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 581
Integrative Proteomic Characterization of Human Lung Adenocarcinoma
Jun‐Yu Xu, Chunchao Zhang, Xiang Wang, et al.
Cell (2020) Vol. 182, Iss. 1, pp. 245-261.e17
Open Access | Times Cited: 454
Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting
Farhad Abasalizadeh, Sevil Vaghefi Moghaddam, Effat Alizadeh, et al.
Journal of Biological Engineering (2020) Vol. 14, Iss. 1
Open Access | Times Cited: 450
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Nick Thatcher, Fred R. Hirsch, Alexander Luft, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 7, pp. 763-774
Open Access | Times Cited: 449
Neutrophils dominate the immune cell composition in non-small cell lung cancer
Julia Kargl, Stephanie Busch, Grace Yang, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 362
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
Jingjing Cong, Xianwei Wang, Xiaohu Zheng, et al.
Cell Metabolism (2018) Vol. 28, Iss. 2, pp. 243-255.e5
Open Access | Times Cited: 288
Metaplasia: tissue injury adaptation and a precursor to the dysplasia–cancer sequence
Véronique Giroux, Anil K. Rustgi
Nature reviews. Cancer (2017) Vol. 17, Iss. 10, pp. 594-604
Open Access | Times Cited: 280
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer
Sha Zhao, Shengxiang Ren, Tao Jiang, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 4, pp. 630-643
Closed Access | Times Cited: 275
HaloTag Technology: A Versatile Platform for Biomedical Applications
Christopher G. England, Haiming Luo, Weibo Cai
Bioconjugate Chemistry (2015) Vol. 26, Iss. 6, pp. 975-986
Open Access | Times Cited: 271
Immune Cell Composition in Human Non-small Cell Lung Cancer
Branislava Stankovic, Heidi Anine Korsmo Bjørhovde, Renate Skarshaug, et al.
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 269
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Beatriz Ballester, Javier Milara, Julio Cortijo
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 593-593
Open Access | Times Cited: 259
N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
Zhenchuan Liu, Tingting Wang, Yunlang She, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 251
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer
Stefan Salcher, Gregor Sturm, Lena Horvath, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1503-1520.e8
Open Access | Times Cited: 233
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
Qingyun Liu, Zubin Yu, Shuai Yuan, et al.
Oncotarget (2016) Vol. 8, Iss. 8, pp. 13048-13058
Open Access | Times Cited: 232
Deciphering the cells of origin of squamous cell carcinomas
Adriana Sánchez‐Danés, Cédric Blanpain
Nature reviews. Cancer (2018) Vol. 18, Iss. 9, pp. 549-561
Open Access | Times Cited: 214
VEGF as a potential target in lung cancer
Daniela Frezzetti, Marianna Gallo, Monica R. Maiello, et al.
Expert Opinion on Therapeutic Targets (2017) Vol. 21, Iss. 10, pp. 959-966
Closed Access | Times Cited: 211
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA
Jie Li, Yi Han, Hongmei Zhang, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 512, Iss. 3, pp. 479-485
Closed Access | Times Cited: 204
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
Masahiro Shibata, Mohammad Obaidul Hoque
Cancers (2019) Vol. 11, Iss. 5, pp. 732-732
Open Access | Times Cited: 195
Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis
Zhiyu Song, Gang Jia, Peizhi Ma, et al.
Life Sciences (2021) Vol. 276, pp. 119399-119399
Closed Access | Times Cited: 195
Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer
Xiaomin Liu, Ping Wang, Caiyan Zhang, et al.
Oncotarget (2017) Vol. 8, Iss. 30, pp. 50209-50220
Open Access | Times Cited: 185
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression
Wen Cai Zhang, Tan Min Chin, Henry Yang, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 182
Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion
Mengfei Guo, Feng Wu, Guorong Hu, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 474
Closed Access | Times Cited: 182
Page 1 - Next Page

Scroll to top